VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, today announces the completion of all validation and verification of the chemiluminescent immunoassay ...
VolitionRx (VNRX) announces the completion of all validation and verification of the chemiluminescent immunoassay version of its Nu.Q Vet Cancer Test with Fujifilm Vet Systems Co. in Japan, allowing ...
HENDERSON, Nev., March 13, 2025 /PRNewswire/ -- VolitionRx Limited (VNRX) ("Volition"), a multi-national epigenetics company, today announced the expansion of its Nu.Q® Vet Cancer Test supply ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results